Ceftazidime Dihydrochloride, identified by its CAS number 73547-70-3, is a foundational compound in the pharmaceutical industry, particularly in the synthesis of advanced antibiotics. As a key intermediate, its chemical structure and properties directly influence the efficacy and safety of the final drug product. NINGBO INNO PHARMCHEM CO.,LTD. is a leading provider of this essential chemical, offering unparalleled purity and reliability for pharmaceutical manufacturers worldwide.

The molecular formula C22H23N6O7S2.Cl.HCl and a molecular weight of 619.49 define the precise composition of Ceftazidime Dihydrochloride. This compound's white powder appearance and solid state make it highly manageable in industrial synthesis settings. The stringent purity levels, often exceeding 98%, are critical for meeting regulatory standards and ensuring that the Ceftazidime produced exhibits its intended broad-spectrum antibacterial activity. Understanding these chemical properties of CAS 73547-70-3 is paramount for optimizing synthesis protocols and achieving high-quality outcomes in antibiotic production.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting the pharmaceutical sector by supplying consistent and high-grade Ceftazidime Dihydrochloride. We recognize that reliable ceftazidime raw material sourcing is a cornerstone for successful antibiotic manufacturing. Our expertise in fine chemicals allows us to provide a product that not only meets but often exceeds industry expectations. For companies looking to buy Ceftazidime Dihydrochloride, our consistent quality control and advanced manufacturing processes ensure a product that contributes significantly to the development of life-saving medicines.

The application of Ceftazidime Dihydrochloride extends to its role as a vital intermediate in the complex journey of drug synthesis. Pharmaceutical manufacturers worldwide rely on dependable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. to procure this essential chemical. We are dedicated to ensuring that our clients have access to the best possible ceftazidime intermediate solutions, supporting innovation and advancement in the field of antibacterial therapeutics.